Operating Margin in % of Cytek Biosciences, Inc. from 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Cytek Biosciences, Inc. quarterly/annual Operating Margin history and change rate from 2020 to Q3 2024.
  • Cytek Biosciences, Inc. Operating Margin for the quarter ending 30 Sep 2024 was -11.8 %, a 90.6% increase year-over-year.
  • Cytek Biosciences, Inc. annual Operating Margin for 2023 was -14.4 %, a 76.3% increase from 2022.
  • Cytek Biosciences, Inc. annual Operating Margin for 2022 was -60.9 %, a 115% decline from 2021.
  • Cytek Biosciences, Inc. annual Operating Margin for 2021 was 420 %, a 78.2% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Cytek Biosciences, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2024 -11.8 +114 +90.6% 01 Jul 2024 30 Sep 2024
Q2 2024 -13.1 +124 +90.4% 01 Apr 2024 30 Jun 2024
Q1 2024 -13.2 +220 +94.3% 01 Jan 2024 31 Mar 2024
Q4 2023 -14.4 +46.5 +76.3% 01 Oct 2023 31 Dec 2023
Q3 2023 -125 -123 -6226% 01 Jul 2023 30 Sep 2023
Q2 2023 -137 -141 -3315% 01 Apr 2023 30 Jun 2023
Q1 2023 -233 -276 -633% 01 Jan 2023 31 Mar 2023
Q4 2022 -60.9 -481 -115% 01 Oct 2022 31 Dec 2022
Q3 2022 -1.98 01 Jul 2022 30 Sep 2022
Q2 2022 4.25 01 Apr 2022 30 Jun 2022
Q1 2022 43.7 01 Jan 2022 31 Mar 2022
Q4 2021 420 01 Oct 2021 31 Dec 2021

Cytek Biosciences, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2023 -14.4 +46.5 +76.3% 01 Jan 2023 31 Dec 2023
2022 -60.9 -481 -115% 01 Jan 2022 31 Dec 2022
2021 420 -1.5K -78.2% 01 Jan 2021 31 Dec 2021
2020 1.92K 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.